CAS NO: | 87190-79-2 |
包装 | 价格(元) |
10mg | 电议 |
25mg | 电议 |
Cas No. | 87190-79-2 |
别名 | CS-92 |
分子式 | C10H14N6O3 |
分子量 | 266.26 |
溶解度 | DMSO : 200 mg/mL (751.15 mM; Need ultrasonic) |
储存条件 | 4°C, away from moisture |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
产品描述 | AzddMeC (CS-92) is an antiviralnucleoside analogueand a potent potent, selective and orally activeHIV-1 reverse transcriptaseandHIV-1 replicationinhibitor. InHIV-1-infected human PBM cells andHIV-1-infected human macrophages, theEC50values of AzddMeC are 9 nM and 6 nM, respectively[1][2]. AzddMeC (CS-92) is also effective against HIV-2 in lymphocytes. The replication of Friend murine virus is only weakly inhibited, and no effect is observed against HSV type 1 and type 2 and coxsackievirus B4. The interaction of the 5'-triphosphate of AzddMeC with HIV-1 reverse transcriptase indicated competitive inhibition (the inhibition constant, Kis, is 9.3 nM)[1]. The pharmacokinetics of AzddMeC are characterized following intravenous and oral administration of 60 mg/kg of the compound to male rhesus monkeys. 3'-azido-3'-deoxythymidine (AZT) is a major metabolite of AzddMeC in monkeys. AzddMeC concentrations in serum declined rapidly in a biexponential fashion with the terminal half-life ranging from 0.5 to 1.3 hr. Renal excretion of unchanged nucleoside and metabolic deamination yielding AZT are the primary routes of AzddMeC clearance. The oral bioavailability is 26%[2]. |